Production (Stage)
Fresh Tracks Therapeutics, Inc.
FRTX
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.87M | 12.02M | 8.95M | 10.76M | 8.68M |
| Total Receivables | 45.00K | -- | 245.00K | 265.00K | 504.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 545.00K | 688.00K | 419.00K | 618.00K | 521.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 94.00K | 305.00K | 97.00K | 166.00K | 378.00K |
| Total Current Assets | 11.55M | 13.01M | 9.71M | 11.81M | 10.08M |
|
|
|||||
| Total Current Assets | 11.55M | 13.01M | 9.71M | 11.81M | 10.08M |
| Net Property, Plant & Equipment | 34.00K | 44.00K | 72.00K | 90.00K | 124.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 61.00K | 64.00K | 64.00K |
| Total Assets | 11.59M | 13.06M | 9.84M | 11.97M | 10.27M |
|
|
|||||
| Total Accounts Payable | 406.00K | 609.00K | 256.00K | 635.00K | 571.00K |
| Total Accrued Expenses | 1.25M | 1.50M | 1.58M | 1.44M | 2.46M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 19.00K | 28.00K | 49.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.66M | 2.11M | 1.85M | 2.10M | 3.08M |
|
|
|||||
| Total Current Liabilities | 1.66M | 2.11M | 1.85M | 2.10M | 3.08M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.66M | 2.11M | 1.85M | 2.10M | 3.08M |
|
|
|||||
| Common Stock & APIC | 182.09M | 181.87M | 181.02M | 180.61M | 173.66M |
| Retained Earnings | -172.16M | -170.93M | -173.03M | -170.75M | -166.47M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 9.93M | 10.95M | 7.99M | 9.87M | 7.19M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9.93M | 10.95M | 7.99M | 9.87M | 7.19M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 9.93M | 10.95M | 7.99M | 9.87M | 7.19M |
|
|
|||||